Recorded via Google Hangouts, Joel Dunning and E. E. John Smith discuss the new international Fellowship of the Royal College of Surgeons qualification.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cardiac
November 18, 2015
This video entails a case report on a 35-year-old carrier of Hemophilia A with a mediastinal mass. The robotic procedure and perioperative management are discussed.
November 17, 2015
The authors report on the extended follow-up of Courage Trial patients for up to 15 years. In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy. At extended follow-up, there was no difference in overall survival between the two treatment strategies.
November 16, 2015
In presentations recorded at the 2015 EACTS Annual Meeting in Amsterdam, The Netherlands, Johannes Bonatti, Franca Melfi, and Carlo Milli discuss topics in robotic cardiothoracic surgery.
November 16, 2015
Data from a large multicenter registry were evaluated to determine whether there is a sex difference in susceptibility to acute kidney injury after CBP related to nadir hematocrit levels. Based on a 21% hematocrit threshold, 9.5% of men and 31.9% of women were affected. Rates of AKI were similar between the sexes. There was a strong interaction be
November 16, 2015
The report of FDA-mandated prospective evaluation of outcomes after Cox Maze-IV for atrial fibrillation during cardiac surgery for other problems. It utilized the Synergy ablation system and focused on absence of AF off antiarrhythmics at 6 months and the absence of major adverse events at 30 days. 76% were AF free, and 9.1% experienced major compl
November 12, 2015
In a roundtable filmed at the 2015 EACTS Annual Meeting in Amsterdam, Marjan Jahangiri and Mattia Glauber share perspectives on the evolution and current state of aortic valve replacement surgery.
November 11, 2015
2 year outcomes of a randomized trial of MV repair vs MV replacement for severe ischemic MR are reported. LVESVI was similar between the two groups. Recurrent moderate or severe MR was higher in the repair group (59% vs 4%). The repair group suffered higher rates of heart failure and hospital readmission. Mortality rates were not different.
November 11, 2015
Results of a multicenter trial of a leadless transcatheter pacing system were reviewed in 300 pts at 6 mos. Implantation was successful in 99%. Safety was assessed as freedom from system-related or procedure related complications, and was 96%. Efficacy was assessed as stable pacing capture at low voltage and was 98%. 25 pts suffered major complic
November 11, 2015
The timing and dosage of preoperative ASA administration was evaluated with regard to CABG outcomes in a series of 3018 pts. Dosing within 24 hrs of surgery was associated with a 50% lower mortality rate and an 81mg dose was associated with a 50% or greater reduction in mortality compared to a 325mg dose or no ASA.